España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Inari Medical
NARI
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$55.45
1.04
1.91%
At close: -
$55.45
0.00
0.00%
After Hours: Dec 20, 4:02 PM EDT
Get Report
Comment
Inari Medical (NARI) Forecast
News
Earnings
Inari Medical (NARI) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Inari Medical (NASDAQ:NARI) Stock
Inari Medical Stock (NASDAQ: NARI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Truist Securities Maintains Hold on Inari Med...
Benzinga Newsdesk
Tuesday, December 17, 2024
Demystifying Inari Medical: Insights From 6 Analyst Reviews
Benzinga Insights
Oppenheimer Initiates Coverage On Inari Medic...
Benzinga Newsdesk
Monday, December 02, 2024
Inari Medical Received National Reimbursement...
Benzinga Newsdesk
Inari Medical Entered Into Joint Venture With...
Benzinga Newsdesk
Wednesday, October 30, 2024
Needham Reiterates Hold on Inari Medical
Benzinga Newsdesk
Tuesday, October 29, 2024
Truist Securities Maintains Hold on Inari Med...
Benzinga Newsdesk
Inari Medical PEERLESS Results Show Superiori...
Benzinga Newsdesk
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Key Takeaways From Inari Medical Analyst Ratings
Benzinga Insights
Canaccord Genuity Maintains Buy on Inari Medi...
Benzinga Newsdesk
Baird Maintains Outperform on Inari Medical, ...
Benzinga Newsdesk
Inari Medical shares are trading higher after...
Benzinga Newsdesk
Piper Sandler Maintains Neutral on Inari Medi...
Benzinga Newsdesk
Needham Reiterates Hold on Inari Medical
Benzinga Newsdesk
Monday, October 28, 2024
Inari Raises FY24 Revenue From $594.5M-$604.5...
Benzinga Newsdesk
Inari Medical Q3 2024 Adj EPS $(0.31) Misses ...
Benzinga Newsdesk
Friday, October 25, 2024
Inari Medical's Earnings: A Preview
Benzinga Insights
Tuesday, October 15, 2024
Inari Medical Partners With American Venous F...
Benzinga Newsdesk
Monday, October 14, 2024
Truist Securities Maintains Hold on Inari Med...
Benzinga Newsdesk
Wednesday, October 09, 2024
Breaking Down Inari Medical: 9 Analysts Share Their Views
Benzinga Insights
Needham Reiterates Hold on Inari Medical
Benzinga Newsdesk
Tuesday, September 17, 2024
Expert Outlook: Inari Medical Through The Eyes Of 9 Analysts
Benzinga Insights
Stifel Initiates Coverage On Inari Medical wi...
Benzinga Newsdesk
Tuesday, September 03, 2024
Leerink Partners Initiates Coverage On Inari ...
Benzinga Newsdesk
Thursday, August 29, 2024
Inari Medical Announces PEERLESS Data To Be P...
Benzinga Newsdesk
Monday, August 26, 2024
FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious
Vandana Singh
Breaking Down Inari Medical: 7 Analysts Share Their Views
Benzinga Insights
Piper Sandler Maintains Neutral on Inari Medi...
Benzinga Newsdesk
Friday, August 09, 2024
Deutsche Bank Initiates Coverage On Inari Med...
Benzinga Newsdesk
Wednesday, July 31, 2024
Inari Medical Q2 Earnings Miss, Revenues Increase Y/Y
Zacks
Wells Fargo Maintains Overweight on Inari Med...
Benzinga Newsdesk
Inari Medical shares are trading lower after ...
Benzinga Newsdesk
Truist Securities Reiterates Hold on Inari Me...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Inari Medi...
Benzinga Newsdesk
Baird Maintains Outperform on Inari Medical, ...
Benzinga Newsdesk
Needham Reiterates Hold on Inari Medical
Benzinga Newsdesk
Tuesday, July 30, 2024
Inari Medical Announces Mitch Hill, CFO, Will...
Benzinga Newsdesk
Inari Medical shares are trading lower after ...
Benzinga Newsdesk
Inari Medical Sees FY24 Revenue $594.5M-$604....
Benzinga Newsdesk
Inari Medical Q2 Sales $146.00M Beat $143.75M...
Benzinga Newsdesk
Thursday, July 25, 2024
William Blair Initiates Coverage On Inari Med...
Benzinga Newsdesk
Thursday, July 18, 2024
Inari Medical shares are trading lower after ...
Benzinga Newsdesk
Needham Downgrades Inari Medical to Hold
Benzinga Newsdesk
Tuesday, July 16, 2024
Deep Dive Into Inari Medical Stock: Analyst Perspectives (5 Ratings)
Benzinga Insights
Truist Securities Maintains Hold on Inari Med...
Benzinga Newsdesk
Tuesday, June 04, 2024
Inari's Expanding Product Portfolio Offsets Competition
Zacks
Thursday, May 23, 2024
Inari Medical Files Patent Infringement Lawsu...
Benzinga Newsdesk
Wednesday, May 01, 2024
Canaccord Genuity Maintains Buy on Inari Medi...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on Inari Med...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch